Enoxaparin is associated with lower rates of thrombosis, kidney injury, and mortality than Unfractionated Heparin in hospitalized COVID patients

Colin Pawlowski, AJ Venkatakrishnan, Christian Kirkup, Gabriela Berner, Arjun Puranik, John C. O’Horo, Andrew D. Badley, Venky Soundararajan
doi: https://doi.org/10.1101/2020.10.06.20208025

Data Availability

All relevant insights are self-contained in the manuscript file and the underlying data was accessed under an IRB approved by the Mayo Clinic

Back to top
Posted October 11, 2020.
Download PDF
Data/Code
Email
Enoxaparin is associated with lower rates of thrombosis, kidney injury, and mortality than Unfractionated Heparin in hospitalized COVID patients
Colin Pawlowski, AJ Venkatakrishnan, Christian Kirkup, Gabriela Berner, Arjun Puranik, John C. O’Horo, Andrew D. Badley, Venky Soundararajan
medRxiv 2020.10.06.20208025; doi: https://doi.org/10.1101/2020.10.06.20208025
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area